The global market for Parenteral Dosage Form was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents鈥� wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Parenteral Dosage Form, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Parenteral Dosage Form by region & country, by Type, and by Application.
The Parenteral Dosage Form market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parenteral Dosage Form.
麻豆原创 Segmentation
By Company
Ashland
Tepnel Pharma Services
Ascendia Pharmaceuticals
Thermo Fisher Scientific
ProJect Pharmaceutics
Lonza
BOC Sciences
Segment by Type:
Emulsions for Injection
Powders for Injection
Gels for Injection
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Parenteral Dosage Form manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Parenteral Dosage Form in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Parenteral Dosage Form in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Parenteral Dosage Form Product Introduction
1.2 Global Parenteral Dosage Form 麻豆原创 Size Forecast
1.2.1 Global Parenteral Dosage Form Sales Value (2019-2030)
1.2.2 Global Parenteral Dosage Form Sales Volume (2019-2030)
1.2.3 Global Parenteral Dosage Form Sales Price (2019-2030)
1.3 Parenteral Dosage Form 麻豆原创 Trends & Drivers
1.3.1 Parenteral Dosage Form Industry Trends
1.3.2 Parenteral Dosage Form 麻豆原创 Drivers & Opportunity
1.3.3 Parenteral Dosage Form 麻豆原创 Challenges
1.3.4 Parenteral Dosage Form 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Parenteral Dosage Form Players Revenue Ranking (2023)
2.2 Global Parenteral Dosage Form Revenue by Company (2019-2024)
2.3 Global Parenteral Dosage Form Players Sales Volume Ranking (2023)
2.4 Global Parenteral Dosage Form Sales Volume by Company Players (2019-2024)
2.5 Global Parenteral Dosage Form Average Price by Company (2019-2024)
2.6 Key Manufacturers Parenteral Dosage Form Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Parenteral Dosage Form Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Parenteral Dosage Form
2.9 Parenteral Dosage Form 麻豆原创 Competitive Analysis
2.9.1 Parenteral Dosage Form 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Parenteral Dosage Form Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parenteral Dosage Form as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Emulsions for Injection
3.1.2 Powders for Injection
3.1.3 Gels for Injection
3.2 Global Parenteral Dosage Form Sales Value by Type
3.2.1 Global Parenteral Dosage Form Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Parenteral Dosage Form Sales Value, by Type (2019-2030)
3.2.3 Global Parenteral Dosage Form Sales Value, by Type (%) (2019-2030)
3.3 Global Parenteral Dosage Form Sales Volume by Type
3.3.1 Global Parenteral Dosage Form Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Parenteral Dosage Form Sales Volume, by Type (2019-2030)
3.3.3 Global Parenteral Dosage Form Sales Volume, by Type (%) (2019-2030)
3.4 Global Parenteral Dosage Form Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Parenteral Dosage Form Sales Value by Application
4.2.1 Global Parenteral Dosage Form Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Parenteral Dosage Form Sales Value, by Application (2019-2030)
4.2.3 Global Parenteral Dosage Form Sales Value, by Application (%) (2019-2030)
4.3 Global Parenteral Dosage Form Sales Volume by Application
4.3.1 Global Parenteral Dosage Form Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Parenteral Dosage Form Sales Volume, by Application (2019-2030)
4.3.3 Global Parenteral Dosage Form Sales Volume, by Application (%) (2019-2030)
4.4 Global Parenteral Dosage Form Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Parenteral Dosage Form Sales Value by Region
5.1.1 Global Parenteral Dosage Form Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Parenteral Dosage Form Sales Value by Region (2019-2024)
5.1.3 Global Parenteral Dosage Form Sales Value by Region (2025-2030)
5.1.4 Global Parenteral Dosage Form Sales Value by Region (%), (2019-2030)
5.2 Global Parenteral Dosage Form Sales Volume by Region
5.2.1 Global Parenteral Dosage Form Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Parenteral Dosage Form Sales Volume by Region (2019-2024)
5.2.3 Global Parenteral Dosage Form Sales Volume by Region (2025-2030)
5.2.4 Global Parenteral Dosage Form Sales Volume by Region (%), (2019-2030)
5.3 Global Parenteral Dosage Form Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Parenteral Dosage Form Sales Value, 2019-2030
5.4.2 North America Parenteral Dosage Form Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Parenteral Dosage Form Sales Value, 2019-2030
5.5.2 Europe Parenteral Dosage Form Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Parenteral Dosage Form Sales Value, 2019-2030
5.6.2 Asia Pacific Parenteral Dosage Form Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Parenteral Dosage Form Sales Value, 2019-2030
5.7.2 South America Parenteral Dosage Form Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Parenteral Dosage Form Sales Value, 2019-2030
5.8.2 Middle East & Africa Parenteral Dosage Form Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Parenteral Dosage Form Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Parenteral Dosage Form Sales Value
6.2.1 Key Countries/Regions Parenteral Dosage Form Sales Value, 2019-2030
6.2.2 Key Countries/Regions Parenteral Dosage Form Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Parenteral Dosage Form Sales Value, 2019-2030
6.3.2 United States Parenteral Dosage Form Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Parenteral Dosage Form Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Parenteral Dosage Form Sales Value, 2019-2030
6.4.2 Europe Parenteral Dosage Form Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Parenteral Dosage Form Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Parenteral Dosage Form Sales Value, 2019-2030
6.5.2 China Parenteral Dosage Form Sales Value by Type (%), 2023 VS 2030
6.5.3 China Parenteral Dosage Form Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Parenteral Dosage Form Sales Value, 2019-2030
6.6.2 Japan Parenteral Dosage Form Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Parenteral Dosage Form Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Parenteral Dosage Form Sales Value, 2019-2030
6.7.2 South Korea Parenteral Dosage Form Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Parenteral Dosage Form Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Parenteral Dosage Form Sales Value, 2019-2030
6.8.2 Southeast Asia Parenteral Dosage Form Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Parenteral Dosage Form Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Parenteral Dosage Form Sales Value, 2019-2030
6.9.2 India Parenteral Dosage Form Sales Value by Type (%), 2023 VS 2030
6.9.3 India Parenteral Dosage Form Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Ashland
7.1.1 Ashland Company Information
7.1.2 Ashland Introduction and Business Overview
7.1.3 Ashland Parenteral Dosage Form Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Ashland Parenteral Dosage Form Product Offerings
7.1.5 Ashland Recent Development
7.2 Tepnel Pharma Services
7.2.1 Tepnel Pharma Services Company Information
7.2.2 Tepnel Pharma Services Introduction and Business Overview
7.2.3 Tepnel Pharma Services Parenteral Dosage Form Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Tepnel Pharma Services Parenteral Dosage Form Product Offerings
7.2.5 Tepnel Pharma Services Recent Development
7.3 Ascendia Pharmaceuticals
7.3.1 Ascendia Pharmaceuticals Company Information
7.3.2 Ascendia Pharmaceuticals Introduction and Business Overview
7.3.3 Ascendia Pharmaceuticals Parenteral Dosage Form Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Ascendia Pharmaceuticals Parenteral Dosage Form Product Offerings
7.3.5 Ascendia Pharmaceuticals Recent Development
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Company Information
7.4.2 Thermo Fisher Scientific Introduction and Business Overview
7.4.3 Thermo Fisher Scientific Parenteral Dosage Form Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Thermo Fisher Scientific Parenteral Dosage Form Product Offerings
7.4.5 Thermo Fisher Scientific Recent Development
7.5 ProJect Pharmaceutics
7.5.1 ProJect Pharmaceutics Company Information
7.5.2 ProJect Pharmaceutics Introduction and Business Overview
7.5.3 ProJect Pharmaceutics Parenteral Dosage Form Sales, Revenue and Gross Margin (2019-2024)
7.5.4 ProJect Pharmaceutics Parenteral Dosage Form Product Offerings
7.5.5 ProJect Pharmaceutics Recent Development
7.6 Lonza
7.6.1 Lonza Company Information
7.6.2 Lonza Introduction and Business Overview
7.6.3 Lonza Parenteral Dosage Form Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Lonza Parenteral Dosage Form Product Offerings
7.6.5 Lonza Recent Development
7.7 BOC Sciences
7.7.1 BOC Sciences Company Information
7.7.2 BOC Sciences Introduction and Business Overview
7.7.3 BOC Sciences Parenteral Dosage Form Sales, Revenue and Gross Margin (2019-2024)
7.7.4 BOC Sciences Parenteral Dosage Form Product Offerings
7.7.5 BOC Sciences Recent Development
8 Industry Chain Analysis
8.1 Parenteral Dosage Form Industrial Chain
8.2 Parenteral Dosage Form Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Parenteral Dosage Form Sales Model
8.5.2 Sales Channel
8.5.3 Parenteral Dosage Form Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Ashland
Tepnel Pharma Services
Ascendia Pharmaceuticals
Thermo Fisher Scientific
ProJect Pharmaceutics
Lonza
BOC Sciences
听
听
*If Applicable.